Literature DB >> 3146708

Focal dendritic swellings in Purkinje cells in mucopolysaccharidoses types I, II and III. A Golgi and ultrastructural study.

I Ferrer1, V Cusí, M Pineda, E Galofré, J Vila.   

Abstract

Focal dendritic swellings in secondary dendrites of Purkinje cells were observed in post-mortem samples of the cerebellum processed by the Golgi method from three patients affected by mucopolysaccharidoses (MPS) types I-H, II and III. These focal dendritic swellings exhibited smooth surfaces but secondary formation of spine-like appendages was absent; in contrast, terminal, spiny branchlets were preserved. Complementary electron-microscopical examination of these samples revealed that membranous cytoplasmic bodies and zebra-like inclusions accounted for the material stored in these focal swellings in MPS I-H and MPS II; in addition, granulomembranous cytosomes with fine, densely-packed membranous profiles were encountered in MPS III. Focal dendritic swellings in Purkinje cells may result in abnormal electrical activity, thus producing informational imbalance on the Purkinje cell dendritic arborization in human mucopolysaccharidoses.

Entities:  

Mesh:

Year:  1988        PMID: 3146708     DOI: 10.1111/j.1365-2990.1988.tb00891.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  11 in total

1.  Increased number of Purkinje cell dendritic swellings in essential tremor.

Authors:  M Yu; K Ma; P L Faust; L S Honig; E Cortés; J-P G Vonsattel; E D Louis
Journal:  Eur J Neurol       Date:  2011-12-05       Impact factor: 6.089

Review 2.  Brain and spinal MR imaging findings in mucopolysaccharidoses: a review.

Authors:  D I Zafeiriou; S P Batzios
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

3.  A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type I.

Authors:  Li Ou; Michael J Przybilla; Ozan Ahlat; Sarah Kim; Paula Overn; Jeanine Jarnes; M Gerard O'Sullivan; Chester B Whitley
Journal:  Mol Ther       Date:  2020-04-08       Impact factor: 11.454

4.  Blood-brain barrier impairment in an animal model of MPS III B.

Authors:  Svitlana Garbuzova-Davis; Michael K Louis; Edward M Haller; Hiranya M Derasari; Ashley E Rawls; Paul R Sanberg
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

5.  Sisyphus in Neverland.

Authors:  Isidro Ferrer
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II.

Authors:  Hélène F E Gleitz; Claire O'Leary; Rebecca J Holley; Brian W Bigger
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

7.  Temporospatial Development of Neuropathologic Findings in a Canine Model of Mucopolysaccharidosis IIIB.

Authors:  Tyler A Harm; Shannon J Hostetter; Ariel S Nenninger; Bethann N Valentine; N Matthew Ellinwood; Jodi D Smith
Journal:  Vet Pathol       Date:  2020-11-18       Impact factor: 2.221

8.  Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B.

Authors:  Coy D Heldermon; Anne K Hennig; Kevin K Ohlemiller; Judith M Ogilvie; Erik D Herzog; Annalisa Breidenbach; Carole Vogler; David F Wozniak; Mark S Sands
Journal:  PLoS One       Date:  2007-08-22       Impact factor: 3.240

9.  Blood-brain barrier impairment in MPS III patients.

Authors:  Svitlana Garbuzova-Davis; Santhia Mirtyl; Sebastian A Sallot; Diana G Hernandez-Ontiveros; Edward Haller; Paul R Sanberg
Journal:  BMC Neurol       Date:  2013-11-13       Impact factor: 2.474

10.  Proteomic Analysis of Mucopolysaccharidosis IIIB Mouse Brain.

Authors:  Valeria De Pasquale; Michele Costanzo; Rosa Anna Siciliano; Maria Fiorella Mazzeo; Valeria Pistorio; Laura Bianchi; Emanuela Marchese; Margherita Ruoppolo; Luigi Michele Pavone; Marianna Caterino
Journal:  Biomolecules       Date:  2020-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.